# GHK-Cu: Research Overview — Winning Edge Peptides > A literature summary of GHK-Cu (copper tripeptide-1), studied for skin regeneration, matrix repair, and hair growth. Covers collagen signaling, the gene-expression evidence, human topical trials, and delivery challenges. A tiny copper-binding tripeptide with the broadest human evidence of the three — most of it on the surface of the skin, where its own delivery problem also lives. ## The short version GHK-Cu is a very small peptide — three amino acids (glycine, histidine, lysine) — bound to a single copper ion. You will also see it called copper tripeptide-1. The same `GHK` sequence occurs naturally inside type I collagen, the main structural protein of skin and tendon, which is a clue to what it does: it signals skin and connective-tissue cells to rebuild their scaffolding of collagen and elastin [16]. Of the three peptides on this desk, GHK-Cu has the most human evidence — but that evidence is mostly *topical*, meaning formulations applied to the skin surface, and it has a built-in limitation: the peptide does not cross intact skin well on its own [13]. Topical copper-peptide cosmetics are legal and widely available; injectable or systemic use is unapproved and research-only [13]. This page summarizes what the studies show and recommends no dose or regimen. ## What it is GHK-Cu is a linear tripeptide, glycyl-L-histidyl-L-lysine, *chelated* (held in a stable molecular grip) one-to-one to a copper(II) ion. The copper is coordinated through the histidine ring, the glycine amino group, and a backbone nitrogen, leaving the lysine side chain free. The bare GHK sequence appears endogenously within the alpha-2(I) chain of type I collagen and in a matrix protein called SPARC/osteonectin — so the body already uses this motif, and copper coordination is required for most of its reported bioactivities [16]. GHK (free tripeptide) and GHK-Cu (copper chelate) are frequently conflated in secondary sources; the form used in a given study matters. ## How it works GHK-Cu plays two roles at once: it is a *copper chaperone* (delivering copper where the cell needs it) and a broad signaling molecule. At very low — picomolar to nanomolar — concentrations it directly stimulates dermal fibroblasts (the skin's matrix-making cells) to synthesize collagen, elastin, glycosaminoglycans and the proteoglycan decorin, while rebalancing the enzymes that break matrix down (matrix metalloproteinases) against their natural inhibitors (TIMPs) [16]. The copper ion enables lysyl-oxidase-mediated cross-linking that knits collagen and elastin together, plus a superoxide-dismutase-like antioxidant action. At the gene level, a Connectivity Map analysis reported that GHK shifts expression of roughly 31.2% of human genes at a 50%-or-greater change threshold (approximately 59% up, 41% down), strongly stimulating protein-quality-control and DNA-repair gene sets [14]. One honest correction belongs here: the widely repeated "~4,000 genes" figure is an extrapolation; the verified 50%-threshold table reports on the order of 2,100 genes [14]. ## What the research shows *Skin regeneration.* The canonical review documents GHK-Cu stimulating synthesis of collagen, dermatan sulfate, chondroitin sulfate and decorin, notes that plasma GHK falls from about 200 ng/mL at age 20 to about 80 ng/mL by age 60, and reports topical GHK-Cu increased collagen production in 70% of treated women versus 50% for vitamin C and 40% for retinoic acid [16]. *Gene expression.* A 2018 analysis quantified the broad transcriptomic shift toward tissue-repair, protein-quality-control, DNA-fidelity and antioxidant programs, though the evidence is gene-expression data requiring protein-level validation [14]. *A controlled human signal.* In a 6-month trial of 45 men with male-pattern hair loss, a complex of 5-aminolevulinic acid plus glycyl-histidyl-lysine peptide increased hair count by 52.6 (at 100 mg/mL) and 71.5 (at 50 mg/mL) versus only 9.6 for placebo, with no adverse events in any group — the strongest controlled human efficacy signal for a GHK-containing topical, though it is a combination product, not pure GHK-Cu [15]. *The delivery problem.* A 2025 review confirms GHK's poor skin permeability (clogP -2.24) as the central challenge, reports procollagen synthesis up in 70% of GHK-Cu-treated subjects, and evaluates fixes such as palmitoylation and microneedle pretreatment (~134 nmol GHK permeated with microneedling versus none through intact skin) [13]. A separate skin-penetration study quantified copper delivery from GHK-Cu through dermatomed human skin, with a measurable dermal copper depot forming over 48 hours [17]. ## Reported effects, cautions & safety Topical copper-peptide products have a long real-world safety record, but several cautions are well documented: - *No approved therapeutic indication.* There is no FDA- or EMA-approved GHK-Cu drug product by any route. Topical copper tripeptide-1 is a legal cosmetic ingredient; injectable or systemic use is unapproved and research-only [13]. - *Thin human evidence beyond skin.* Human clinical data are limited to small topical dermatology trials and the single 45-patient combination hair-loss study — no validated human pharmacokinetic data for injectable or systemic GHK-Cu exists, so community dosing protocols have no peer-reviewed basis [15]. - *Pigmentation risk.* Localized hyperpigmentation has been reported with some topical copper-peptide applications — for example around 40% in one acne-scar microneedling study. - *Formulation incompatibility.* Vitamin C and low-pH acids can destroy both actives through copper interactions — a real user-error risk. - *Single-investigator origin.* A large share of foundational mechanistic and review literature comes from one investigator and colleagues, limiting independent replication of broader anti-aging and gene-expression claims [14]. No community-anecdote signals are compiled in this desk's source material for GHK-Cu, so none are presented; the cautions above come from the cited literature. ## Where it fits in recovery research GHK-Cu is the matrix-and-skin specialist of the group, and the one with the strongest human footing — but that footing is mostly on the skin surface, where its own delivery problem caps how far the evidence reaches [13]. Where [BPC-157](/bpc-157) and [TB-500](/tb-500) live almost entirely in animal models, GHK-Cu has decades of topical cosmetic use behind it; what it lacks is validated systemic human data. It rounds out the desk's repair picture with the scaffolding angle — the actual rebuilding of collagen and elastin. Compare all three on the [comparison page](/compare). ![GHK-Cu research illustration showing copper tripeptide and collagen lattice in cold cyan graphite](/images/ghk-cu.webp) --- Peer-reviewed findings, reported straight — no prescriptions, no products, no dose recommendations.